Delivery Order SPE2DB20D1100-SPE2DB25FA1G0

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,908,730 units of Tranexamic 1,000 mg/100 ml Sodium Chloride 100 ml, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price of $3,675.54 and a period of performance through January 14, 2025. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,130.36, is for the procurement of 4566947039 - TRANEXAMIC 1,000 MG/100ML-NACL 100ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for 4,566,597,644 units of Tranexamic 1,000 mg/100 ml-Nacl 100 ml, a pharmaceutical product, at a ceiling value of $1,894.24. The contract has a firm fixed price and a completion date of December 4, 2024. This delivery order is part of a larger IDC that provides a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,926.23, is for the delivery of 4567290205 TRANEXAMIC 1000MG 10S, a medical product used in healthcare settings. The contract is a delivery order with a firm fixed price pricing type, and has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,799.06, is for the delivery of Tranexamic Acid 650 mg tablets to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,058.40, is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of January 6, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,554.08, is for the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of February 5, 2025....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,104.30, is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of January 7, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $134,971.65, covers the delivery of a range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract has an ultimate completion date of December 12, 2023 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $151,012.84, is for the provision of a range of medical products and supplies to support TRICARE, the military healthcare program. The contract is a firm fixed-price delivery order, with no set-aside designation, and has a completion date of November 6, 2015....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA1G0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,253.28, is for the delivery of 4567258486 - Tranexamic 1,000 mg/100 ml-Nacl 100 ml medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is not designated as a set-aside and was awarded through open competition.

Generated 4/18/25, 2:13 AM